ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,345, issued on Aug. 4, was assigned to Kashiv BioSciences LLC (Piscataway, N.J.).
"Process for improving Omalizumab expression in CHO cells" was invented by Kaumil Bhupendra Bhai Bhavsar (Ahmedabad, India), Ghanshyam Madhabhai Patel (Gandhinagar, India) and Parth Hitarthbhai Vaishnav (Jamnagar, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process of improving the production of anti-IgE antibody specifically Omalizumab with improved titer and reduced galactosylation and/or reduced acidic variant expressed in mammalian cell culture in suitable culture condition for an example using fed batch mode by maintainin...